Երկիր: Ամերիկայի Միացյալ Նահանգներ
Լեզու: անգլերեն
Աղբյուրը: NLM (National Library of Medicine)
ACYCLOVIR SODIUM (UNII: 927L42J563) (ACYCLOVIR - UNII:X4HES1O11F)
AuroMedics Pharma LLC
ACYCLOVIR SODIUM
ACYCLOVIR 500 mg in 10 mL
INTRAVENOUS
PRESCRIPTION DRUG
Acyclovir Sodium Injection is indicated for the treatment of initial and recurrent mucosal and cutaneous herpes simplex (HSV-1 and HSV-2) in immunocompromised patients. Acyclovir Sodium Injection is indicated for the treatment of severe initial clinical episodes of herpes genitalis in immuno-competent patients. Acyclovir Sodium Injection is indicated for the treatment of herpes simplex encephalitis. Acyclovir Sodium Injection is indicated for the treatment of neonatal herpes infections. Acyclovir Sodium Injection is indicated for the treatment of varicella-zoster (shingles) infections in immunocompromised patients. Acyclovir Sodium Injection is contraindicated for patients who develop hypersensitivity to acyclovir or valacyclovir.
Acyclovir Sodium Injection is a clear, colorless solution and is available as: Acyclovir Sodium Injection equivalent to acyclovir, NDC 55150-154-11 50 mg/mL in 10 mL glass vials, in a Carton of 10. Acyclovir Sodium Injection equivalent to acyclovir, NDC 55150-155-21 50 mg/mL in 20 mL glass vials, in a Carton of 10. Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Discard unused portion. Vial stoppers are not made with natural rubber latex. Retain in Carton until time of use. Sterile, Nonpyrogenic Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520 Manufactured by: Aurobindo Pharma Limited Hyderabad - 500038 India NOVAPLUS is a registered trademark of Vizient, Inc. Revised: September 2017
Abbreviated New Drug Application
ACYCLOVIR SODIUM - ACYCLOVIR SODIUM INJECTION, SOLUTION AUROMEDICS PHARMA LLC ---------- ACYCLOVIR SODIUM INJECTION FOR INTRAVENOUS INFUSION ONLY RX ONLY DESCRIPTION Acyclovir Sodium Injection is a synthetic nucleoside analog, active against herpes viruses. It is a sterile, aqueous solution for intravenous infusion, containing 50 mg acyclovir per mL in Water for Injection, USP. The concentration is equivalent to 54.9 mg of acyclovir sodium per mL in Water for Injection, USP. The sodium content is approximately 5.1 mg/mL. The pH range of the solution is 10.85 to 11.50. Further dilution of Acyclovir Sodium Injection in an appropriate intravenous solution must be performed before infusion (see DOSAGE AND ADMINISTRATION, ADMINISTRATION). The chemical name of acyclovir sodium is 9-[(2-Hydroxyethoxy)methyl] guanine, and has the following structural formula: Acyclovir USP is a white to off-white, crystalline powder. Acyclovir sodium is the sodium salt of acyclovir, which is formed _in situ_, with the molecular formula C H N NaO and a molecular weight of 247.19. The maximum solubility in water at 25°C exceeds 100 mg/mL. At physiologic pH, acyclovir sodium exists as the unionized form with a molecular weight of 225 and a maximum solubility in water at 37°C of 2.5 mg/mL. The pka’s of acyclovir are 2.27 and 9.25. VIROLOGY MECHANISM OF ANTIVIRAL ACTION Acyclovir is a synthetic purine nucleoside analogue with _in vitro_ and _in vivo_ inhibitory activity against herpes simplex virus types 1 (HSV-1), 2 (HSV-2) and varicella-zoster virus (VZV). The inhibitory activity of acyclovir is highly selective due to its affinity for the enzyme thymidine kinase (TK) encoded by HSV and VZV. This viral enzyme converts acyclovir into acyclovir monophosphate, a nucleotide analogue. The monophosphate is further converted into diphosphate by cellular guanylate kinase and into triphosphate by a number of cellular enzymes. _In vitro_, acyclovir triphosphate stops replication of herpes viral DNA. This is accomplished in three ways: 1) competit Կարդացեք ամբողջական փաստաթուղթը